Jpmorgan Chase & CO Haemonetics Corp Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Haemonetics Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 156,819 shares of HAE stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

156,819

Previous 193,565 18.98%

Holding current value

$12.6 Million

Previous $16.5 Million 21.47%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$81.24 - $97.37 $2.99 Million - $3.58 Million	-36,746 Reduced 18.98%	156,819 $13 Million
Q1 2024 May 10, 2024	BUY	$71.24 - $85.35 $1.23 Million - $1.47 Million	17,226 Added 9.77%	193,565 $16.5 Million
Q4 2023 Feb 12, 2024	BUY	$80.59 - $92.61 $399,887 - $459,530	4,962 Added 2.9%	176,339 $15.1 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $1.35 Million - $1.52 Million	-16,301 Reduced 8.69%	171,377 $15.4 Million
Q2 2023 Aug 11, 2023	BUY	$80.84 - $89.45 $791,181 - $875,447	9,787 Added 5.5%	187,678 $16 Million
Q1 2023 May 18, 2023	BUY	$72.75 - $90.6 $9.1 Million - $11.3 Million	125,116 Added 237.07%	177,891 $14.7 Million
Q1 2023 May 11, 2023	SELL	$72.75 - $90.6 $7.31 Million - $9.1 Million	-100,430 Reduced 65.55%	52,775 $4.37 Million
Q4 2022 Feb 13, 2023	BUY	$73.85 - $86.14 $498,635 - $581,617	6,752 Added 4.61%	153,205 $12 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $748,712 - $930,390	11,828 Added 8.79%	146,453 $10.8 Million
Q2 2022 Aug 11, 2022	SELL	$49.27 - $66.08 $22,368 - $30,000	-454 Reduced 0.34%	134,625 $8.77 Million
Q1 2022 May 11, 2022	BUY	$43.77 - $63.22 $1.14 Million - $1.64 Million	26,017 Added 23.86%	135,079 $8.54 Million
Q4 2021 Feb 10, 2022	SELL	$49.55 - $74.59 $202,709 - $305,147	-4,091 Reduced 3.62%	109,062 $5.78 Million
Q3 2021 Nov 12, 2021	BUY	$57.6 - $70.59 $6.52 Million - $7.99 Million	113,153 New	113,153 $7.99 Million

Others Institutions Holding HAE

# of Institutions

337

Shares Held

55.2M

Call Options Held

383K

Put Options Held

45.1K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.12B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Haemonetics Corp Transaction History